Search Results - "Doshi, Jalpa A."

Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3] by Lakdawalla, Darius N., Doshi, Jalpa A., Garrison, Louis P., Phelps, Charles E., Basu, Anirban, Danzon, Patricia M.

“…The third section of our Special Task Force report identifies and defines a series of elements that warrant consideration in value assessments of medical…”
Get full text

Economic Impact of Childhood and Adult Attention-Deficit/Hyperactivity Disorder in the United States by Doshi, Jalpa A., Ph.D, Hodgkins, Paul, Ph.D, Kahle, Jennifer, Ph.D, Sikirica, Vanja, Pharm.D, Cangelosi, Michael J., M.P.H, Setyawan, Juliana, Pharm.D, Erder, M. Haim, Ph.D, Neumann, Peter J., Sc.D

“…Objective Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent mental disorders in children in the United States and often persists…”
Get full text

Antipsychotic utilization, healthcare resource use and costs, and quality of care among fee-for-service Medicare beneficiaries with schizophrenia in the United States by Li, Pengxiang, Benson, Carmela, Geng, Zhi, Seo, Sanghyuk, Patel, Charmi, Doshi, Jalpa A

“…No research to date has examined antipsychotic (AP) use, healthcare resource use (HRU), costs, and quality of care among those with schizophrenia in the…”
Get more information

Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population by Doshi, Jalpa A., PhD, Takeshita, Junko, MD, PhD, Pinto, Lionel, MS, Li, Penxiang, PhD, Yu, Xinyan, MD, MS, Rao, Preethi, MS, Viswanathan, Hema N., PhD, Gelfand, Joel M., MD, MSCE

“…Background Studies indicate adherence to biologics among patients with psoriasis is low, yet little is known about their use in the Medicare population…”
Get full text

Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment before and after Implementation of Quality-Related Bonus Payments in 2012 by Li, Pengxiang, Doshi, Jalpa A

“…Since 2007, the Centers for Medicare and Medicaid Services have published 5-star quality rating measures to aid consumers in choosing Medicare Advantage…”
Get full text

Measurement and Rates of Persistence With and Adherence to Biologics for Rheumatoid Arthritis: A Systematic Review by Blum, Marissa A., MD, Koo, Danielle, Doshi, Jalpa A., BPharm, PhD

“…Abstract Background Biologics are an important addition to the conventional care of patients with rheumatoid arthritis (RA). Poor persistence with and…”
Get full text

Comparison of the performance of the CMS Hierarchical Condition Category (CMS-HCC) risk adjuster with the Charlson and Elixhauser comorbidity measures in predicting mortality by Li, Pengxiang, Kim, Michelle M, Doshi, Jalpa A

“…The Centers for Medicare and Medicaid Services (CMS) has implemented the CMS-Hierarchical Condition Category (CMS-HCC) model to risk adjust Medicare capitation…”
Get full text

Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study by Huntington, Scott F, Dr, Weiss, Brendan M, MD, Vogl, Dan T, MD, Cohen, Adam D, MD, Garfall, Alfred L, MD, Mangan, Patricia A, CRNP, Doshi, Jalpa A, PhD, Stadtmauer, Edward A, Prof

“…Summary Background Financial toxicity is increasingly recognised as adversely affecting the quality of life and medication adherence in patients with cancer in…”
Get full text

Randomized trial of lottery-based incentives to improve warfarin adherence by Kimmel, Stephen E., MD, MSCE, Troxel, Andrea B., ScD, Loewenstein, George, PhD, Brensinger, Colleen M., MS, Jaskowiak, Jane, BSN, RN, Doshi, Jalpa A., PhD, Laskin, Mitchell, RPh, Volpp, Kevin, MD, PhD

“…Background Poor adherence to medications is a major cause of morbidity and inadequate drug effectiveness. Efforts to improve adherence have typically been…”
Get full text

Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era by Mato, Anthony, Jahnke, Jordan, Li, Pengxiang, Mehra, Maneesha, Ladage, Vrushabh P, Mahler, Michelle, Huntington, Scott, Doshi, Jalpa A

Get full text

Advancing High-Quality Value Assessments of Health Care Interventions by Doshi, Jalpa A., PhD, Willke, Richard J., PhD

Get full text

Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge by Doshi, Jalpa A, Pettit, Amy R, Stoddard, Jeffrey J, Zummo, Jacqueline, Marcus, Steven C

“…Pharmacological treatment is central to effective management of schizophrenia. Prescribing clinicians have an increasing array of options from which to choose,…”
Get full text

Depression and Retirement in Late Middle‐Aged U.S. Workers by Doshi, Jalpa A., Cen, Liyi, Polsky, Daniel

“…Objective. To determine whether late middle‐aged U.S. workers with depression are at an increased risk for retirement. Data Source. Six biennial waves…”
Get full text

Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data by Dodick, David W., Shewale, Anand S., Lipton, Richard B., Baum, Seth J., Marcus, Steven C., Silberstein, Stephen D., Pavlovic, Jelena M., Bennett, Nathan L., Young, William B., Viswanathan, Hema N., Doshi, Jalpa A., Weintraub, Howard

“…Introduction: Triptans, the most commonly prescribed acute treatments for migraine attacks are, per FDA labeling, contraindicated in cardiovascular (CV)…”
Get full text

Adherence, Discontinuation, and Switching of Biologic Therapies in Medicaid Enrollees with Rheumatoid Arthritis by Li, Pengxiang, PhD, Blum, Marissa A., MD, Von Feldt, Joan, MD, Hennessy, Sean, PharmD, PhD, Doshi, Jalpa A., PhD

“…Abstract Objective This study examined adherence, discontinuation, and switching of rheumatoid arthritis (RA) biologics over a 1-year period after initiation…”
Get full text

Increased Persistency in Medication Use by U.S. Medicare Beneficiaries With Diabetes Is Associated With Lower Hospitalization Rates and Cost Savings by Stuart, Bruce C, Simoni-Wastila, Linda, Zhao, Lirong, Lloyd, Jennifer T, Doshi, Jalpa A

“…OBJECTIVE: To assess the relationship between annual fills for antidiabetes medications, ACE inhibitors, angiotensin II receptor blockers (ARBs), and…”
Get full text

Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic by Asch, David A, Sheils, Natalie E, Islam, Md Nazmul, Chen, Yong, Werner, Rachel M, Buresh, John, Doshi, Jalpa A

“…It is unknown how much the mortality of patients with coronavirus disease 2019 (COVID-19) depends on the hospital that cares for them, and whether COVID-19…”
Get more information

The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report by McGhan, William F., PharmD, PhD, Al, Maiwenn, PhD, Doshi, Jalpa A., PhD, Kamae, Isao, MD, DrPH, Marx, Steven E., PharmD, MS, Rindress, Donna, PhD

“…ABSTRACT Objectives The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Health Science Policy Council recommended and the ISPOR Board…”
Get full text

Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006 by Li, Pengxiang, Schwartz, J. Sanford, Doshi, Jalpa A.

“…Background Cost sharing is widely used to encourage therapeutic substitution. This study aimed to examine the impact of increases in patient cost‐sharing…”
Get full text

Factors associated with antimicrobial drug use in medicaid programs by Li, Pengxiang, Metlay, Joshua P, Marcus, Steven C, Doshi, Jalpa A

“…Using US Medicaid data, we found that 52% of adult Medicaid patients with acute respiratory tract infections filled prescriptions for antimicrobial drugs in…”
Get full text